Brenig Therapeutics Funding: $65M Raised, Series A (2024)

Brenig Therapeutics is based in Amsterdam, Netherlands. It has raised $65M in total funding. Latest round: Series A.

Brenig Therapeutics funding overview

Brenig Therapeutics is based in Amsterdam, Netherlands. Brenig Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2024. The round record for Brenig Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include New Enterprise Associates, OrbiMed, Torrey Pines Investments, BioGeneration Ventures. 4 distinct backers are named across the disclosed rounds.

Brenig Therapeutics at a glance

Total raised
$65M
Latest round
Series A
Latest round date
July 2024
Headquarters
Amsterdam, Netherlands
Notable investors
New Enterprise Associates, OrbiMed, Torrey Pines Investments, BioGeneration Ventures

Frequently asked about Brenig Therapeutics funding

How much has Brenig Therapeutics raised?
Brenig Therapeutics has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Brenig Therapeutics?
New Enterprise Associates, OrbiMed, Torrey Pines Investments, BioGeneration Ventures are named among the investors backing Brenig Therapeutics.
What was the latest Brenig Therapeutics funding round?
The most recent disclosed round is a Series A, announced in July 2024.
Where is Brenig Therapeutics based?
Brenig Therapeutics is based in Amsterdam, Netherlands.
When did Brenig Therapeutics last raise?
The last disclosed Brenig Therapeutics round closed in July 2024 at Series A.

Round data for Brenig Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Amsterdam and backer lists below.

Companies related to Brenig Therapeutics (36)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades